LOWERING PARATHYROID HORMONE LEVEL IN PATIENTS ON HEMODIOALYSIS

Clinical trials for LOWERING PARATHYROID HORMONE LEVEL IN PATIENTS ON HEMODIOALYSIS explained in plain language.

Never miss a new study

Get alerted when new LOWERING PARATHYROID HORMONE LEVEL IN PATIENTS ON HEMODIOALYSIS trials appear

Sign up with your email to follow new studies for LOWERING PARATHYROID HORMONE LEVEL IN PATIENTS ON HEMODIOALYSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Dialysis drug showdown: which vitamin d works best?

Disease control Not yet recruiting

This study compares two vitamin D medications—doxercalciferol (given through a vein) and calcitriol (taken by mouth)—to see which is better at lowering parathyroid hormone levels in kidney dialysis patients. About 98 adults on dialysis with high parathyroid hormone will take part…

Matched conditions: LOWERING PARATHYROID HORMONE LEVEL IN PATIENTS ON HEMODIOALYSIS

Phase: NA • Sponsor: Chittagong Medical College • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

LOWERING PARATHYROID HORMONE LEVEL IN PATIENTS ON HEMODIOALYSIS

Get alerted when new LOWERING PARATHYROID HORMONE LEVEL IN PATIENTS ON HEMODIOALYSIS trials appear

Dialysis drug showdown: which vitamin d works best?